Atlas Trials

Celecoxib and Erlotinib in Treating Patients With Liver Cancer

Clinical trial NCT00293436 · WITHDRAWN

Trial details

NCT number
NCT00293436
Sponsor
University of California, San Francisco
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Liver Cancer
Start date
2005-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.